Rosonabant - CAS 861151-12-4
Catalog number: 861151-12-4
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
Cannabinoid Receptor
Rosonabant is a CB1 receptor antagonist/inverse agonist originated by Esteve. It is an appetite suppressant for the treatment of obesity. But development of the drug for clinical use was apparently halted shortly after the related CB1 antagonist rimonabant was discontinued.
E-6776; E 6776; E6776; Rosonabant; (R)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-4,5-dihydro-1H-pyrazole-3-carboxamide
Soluble in DMSO
-20℃ Freezer
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Canonical SMILES:
Current Developer:
Originator Esteve
1.Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.
Janero DR;Makriyannis A Expert Opin Emerg Drugs. 2009 Mar;14(1):43-65. doi: 10.1517/14728210902736568 .
The endogenous cannabinoid (CB) (endocannabinoid) signaling system is involved in a variety of (patho)physiological processes, primarily by virtue of natural, arachidonic acid-derived lipids (endocannabinoids) that activate G protein-coupled CB1 and CB2 receptors. A hyperactive endocannabinoid system appears to contribute to the etiology of several disease states that constitute significant global threats to human health. Consequently, mounting interest surrounds the design and profiling of receptor-targeted CB antagonists as pharmacotherapeutics that attenuate endocannabinoid transmission for salutary gain. Experimental and clinical evidence supports the therapeutic potential of CB1 receptor antagonists to treat overweight/obesity, obesity-related cardiometabolic disorders, and substance abuse. Laboratory data suggest that CB2 receptor antagonists might be effective immunomodulatory and, perhaps, anti-inflammatory drugs. One CB1 receptor antagonist/inverse agonist, rimonabant, has emerged as the first-in-class drug approved outside the United States for weight control. Select follow-on agents (taranabant, otenabant, surinabant, rosonabant, SLV-319, AVE1625, V24343) have also been studied in the clinic.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Cannabinoid Receptor Products

CAS 176977-56-3 LY 320135

LY 320135
(CAS: 176977-56-3)

LY 320135 is a selective CB1 receptor antagonist.

CAS 251908-92-6 AM 1172

AM 1172
(CAS: 251908-92-6)

AM 1172, an AEA analogue, has been found to be an anandamide uptake inhibitor as well as a cannabinoid receptor partial agonist.

CAS 164178-33-0 Iodopravadoline (AM630)

Iodopravadoline (AM630)
(CAS: 164178-33-0)

Iodopravadoline, also known as AM630, is an inverse agonist at the human cannabinoid CB1 receptor. Iodopravadoline has been found to attenuate the ability of a ...

CAS 406205-74-1 BAY 59-3074

BAY 59-3074
(CAS: 406205-74-1)

Bay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist(Ki values are 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively).

CAS 259869-55-1 JWH 133

JWH 133
(CAS: 259869-55-1)

JWH 133 is a synthetic cannabinoid and acts as a potent CB2 selective agonist with Ki value of 3.4 nM. It is used to synthesize CB2-selective cannabinoid recept...

CAS 1446-61-3 Leelamine

(CAS: 1446-61-3)

Leelamine, a diterpene molecule, has weak affinity for the human central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. Leelamine is also a PDK(p...

CAS 1245626-05-4 AM 6545

AM 6545
(CAS: 1245626-05-4)

AM 6545 has been found to be a CB1 antagonist and could probably be used as an appetite suppressant.

CAS 1048039-15-1 COR 170

COR 170
(CAS: 1048039-15-1)

COR 170 has been found to be an inverse agonist of CB2 receptors and could be used in studies for CB1 and CB2 receptor affinity.

Chemical Structure

CAS 861151-12-4 Rosonabant

Quick Inquiry

Verification code

Featured Items